"The capacity to detect new cancers, treatment-resistant variants, and tumor heterogeneity by noninvasive technology on the basis of tumor DNA in the blood promises to revolutionize cancer detection, prevention, and treatment." 1
Do you want to use liquid biopsy for designing targeted therapy regimes or monitoring cancer progression – but don’t know, with confidence, which mutation(s) would be best to target? We’ll help you find out what is driving the cancer and then design a custom liquid biopsy test just for you.
Liquid Biopsy Labs’ revolutionary test allows doctors and their patients to have supreme confidence in their treatment decisions, and to monitor treatment efficacy with 99+% accuracy!
Precision oncology – the most precise cancer care that medical science offers today – should not involve guessing or hoping...but, with traditional liquid biopsy testing, that’s just what you’re doing (whether you know it or not).
With Liquid Biopsy Labs’ unique, personalized, and precise testing protocol, you’ll have true confidence in your cancer treatment plan.
Cancer patients don’t have time to guess or hope that a treatment is working. But the current standard approach of measuring the size of a tumor over time (i.e. 3 months) can easily result in a patient being on the wrong drug. And this can result in two negative consequences:
Our unique, designed just for you, liquid biopsy test ensures that you have 99+% confidence that the mutation you’re targeting is involved in driving the cancer. And, our ongoing cancer treatment monitoring package lets you know, within just a few weeks of treatment initiation, whether or not the treatment is working as you’d expected.
"Doctors do very well in improving lives of people whose cancers are screened and detected before symptoms occur. Five-year survival rates increase dramatically if cancer is detected at an early stage." 2
After nine years of researching many different liquid biopsy tests from around the world – including the use of additional diagnostic tools such as broad panel genetic testing and PET/CT, all with the goal of identifying the most accurate treatment targets – Alexander Rolland, Chief Research Scientist and co-founder of Liquid Biopsy Labs, has designed a test that can confidently be used for both discovery and for monitoring how well a treatment is working.
The most important identifier of how well your cancer treatment is working is not the number of dead cancer cells in your blood, which is the measure used by standard Liquid Biopsy tests. In fact, that commonly used measurement tells you very little about how well your cancer care is working. Think about it – just because some cancer cells are dying, doesn’t mean your body isn’t producing even more of them.
In order to have confidence that your treatment plan is working as well as hoped, the information you need is the measurement of how many new cells, carrying your cancerous mutation, are still being produced by your body. Liquid Biopsy Labs is the only liquid biopsy company in the world today to prioritize the monitoring of this crucial indicator of treatment success. We use a rigorous, proprietary method of identifying and isolating exosomal DNA.
Our analysis is based entirely on exosomal DNA and, therefore, is indicative of metastatic process. We use positive and negative controls to ensure that our information is accurate. This is also unheard of in standard liquid biopsy testing. And it means that, with 99+% confidence, you can tell if the cancer is growing or not.
And, with Liquid Biopsy Labs tests, you can see any new tumor growth more than 8 months before tumors would be visible through even the most advanced imaging diagnostics, such as PET/CT.
Our test includes verification of the mutation – not just showing if it is present, which again, tells you nothing about what will work for treatment. Instead, our test shows you whether or not a mutation is causative or problematic. So you don’t waste time targeting the wrong mutation.
For even greater precision, we use a two step identification process:
This one element alone can differ greatly from person to person. And, if not assessed for, can lead to completely inaccurate treatment choices and lots of wasted time and money for the medical system and, most importantly, for the patient.
Liquid Biopsy Labs tests ensure that every targeted treatment is truly matched to the patient, and that a personalized monitoring test is designed for their unique mutations.
Our unique patent-pending test quantitatively measures the amount of a tumor-causing mutation in the blood. Therefore, it is used for a) discovery and b) the creation of a targeted treatment plan that gives you the most accurate targets for each patient, leading to significantly higher survival rates and greatly reduced treatment side effects.
The use of Liquid Biopsy Labs’ unique Liquid Biopsy test allows you to experience previously unheard of precision in treatment monitoring – providing cancer patients with the best possible outcome that medical science can offer today.
"Adding blood-based liquid biopsy testing nearly doubled the number of mutations detected in non-small cell lung cancer (NSCLC) compared to solid tissue testing alone." 3
While most liquid biopsy companies claim 90% validity, the erroneous assumptions they make up front, and their lack of personalized testing for naturally occuring mutations, make their results impossible to trust. Hence, many cancer patients think they’re getting targeted therapies – and may even be paying thousands of dollars a month – when, in reality, they’re wasting valuable time and money on the wrong treatment.
Why waste time and money on the wrong treatment when you could instead know – with 99+% confidence – that the targeted therapy you’re using is the right one? When used correctly, targeted therapies have been proven to provide cancer patients with significantly better survival rates and far fewer treatment-related side effects.
Wouldn’t you want to ensure that the mutation you’re targeting is the right one?
Don’t guess, don’t take chances, don’t just hope for the best.
KNOW, with confidence, that the mutation you’re targeting is actually involved in driving the cancer.
Liquid Biopsy Labs' unique, designed just for you, liquid biopsy test ensures that you have 99+% confidence that the mutation you’re targeting is involved in driving the cancer. And, our ongoing cancer treatment monitoring package lets you know, within just a few weeks of treatment initiation, whether or not the treatment is working as you’d expected.
Contact us for information on how to partner with us to ensure you have the most accurate information from which to treat your patients.
For individuals with cancer, please visit our sister site, CTOAM, for Precision Oncology services designed just for you and your care team. CTOAM will coordinate your precision diagnosis – including your personalized liquid biopsy tests – and develop a targeted therapy plan based on what is truly causing your cancer to grow. CTOAM will partner with your Oncologist to administer and monitor the very best treatment for your cancer.